» Articles » PMID: 17991205

Body Mass Index and Peritoneal Dialysis: "exceptions to the Exception" in Reverse Epidemiology?

Overview
Journal Semin Dial
Specialty Nephrology
Date 2007 Nov 10
PMID 17991205
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Until recently, it was not apparent whether apparent paradoxical associations of body mass index (BMI), lipids, and blood pressure with survival observed in hemodialysis (HD) patients, which contradict observations from the general population, also applied to peritoneal dialysis (PD) patients. Studies of survival in PD patients must account for differences in adjusted survival relative to HD patients, namely, early equivalent to superior survival, but after about 1-2 years, inferior survival. Several recent observational studies have analyzed the association between BMI and survival in PD patients from different perspectives and using different patient populations. In general, these studies found that any survival advantage associated with obesity is significantly less likely in PD than HD patients. Among PD patients, those who are obese can be said to have equivalent survival to PD patients with normal BMI. Studies of lipids and blood pressure in PD patients also yield conflicting associations with survival. Obese patients, especially if diabetic, may have increased risk of death after starting on PD compared to HD, although firm conclusions are premature given the limitations of current evidence. At present, the levels of lipids and blood pressure which are best associated with survival in PD patients are not well-defined.

Citing Articles

Metabolic Syndrome Increases Mortality Risk in Dialysis Patients: A Systematic Review and Meta-Analysis.

Sanguankeo A, Upala S Int J Endocrinol Metab. 2018; 16(2):e61201.

PMID: 30323848 PMC: 6176464. DOI: 10.5812/ijem.61201.


Obesity Paradox in Advanced Kidney Disease: From Bedside to the Bench.

Naderi N, Kleine C, Park C, Hsiung J, Soohoo M, Tantisattamo E Prog Cardiovasc Dis. 2018; 61(2):168-181.

PMID: 29981348 PMC: 6131022. DOI: 10.1016/j.pcad.2018.07.001.


Educating end-stage renal disease patients on dialysis modality selection.

Covic A, Bammens B, Lobbedez T, Segall L, Heimburger O, Van Biesen W NDT Plus. 2017; 3(3):225-233.

PMID: 28657058 PMC: 5477971. DOI: 10.1093/ndtplus/sfq059.


Excessive Weight Gain during the First Year of Peritoneal Dialysis Is Associated with Inflammation, Diabetes Mellitus, and a Rapid Decrease in Residual Renal Function.

Kim J, Kim Y, Song Y, Kim H, Kim S, Moon S PLoS One. 2015; 10(9):e0139033.

PMID: 26406589 PMC: 4583287. DOI: 10.1371/journal.pone.0139033.


Obesity paradox in end-stage kidney disease patients.

Park J, Ahmadi S, Streja E, Molnar M, Flegal K, Gillen D Prog Cardiovasc Dis. 2014; 56(4):415-25.

PMID: 24438733 PMC: 4733536. DOI: 10.1016/j.pcad.2013.10.005.